Independent Director's Work Report (Zhang Xingliang)
In 2025, I, as the independent director of Nantong Taihe Chemical Co., Ltd. (hereinafter referred to as "the Company"), strictly adhered to the Company Law of the People's Republic of China, the Management Measures for Independent Directors of Listed Companies, the Listing Rules of the Shenzhen Stock Exchange for the Growth Enterprise Market, and the Self-Regulatory Guidelines No. 2 for Listed Companies on the Shenzhen Stock Exchange, as well as the Company's Articles of Association and the Independent Director Work System. I faithfully fulfilled my duties as an independent director, actively participating in decision-making, supervision, and providing professional advice to safeguard the overall interests of the listed company and protect the legitimate rights and interests of minority shareholders. Below is my work report for 2025:
I. Basic Information
Zhang Xingliang, born in December 1975, holds a doctoral degree, is a Chinese national, and has no permanent residency abroad. I am a professor. From August 1997 to August 2004, I served successively as a staff member and deputy director in the Department of Economic Management at Jiangsu Ocean University; from July 2006 to June 2017, I served as a lecturer and associate professor at Jiaxing University Business School; since July 2017, I have served as an associate professor and professor at the School of Accounting, Nanjing Audit University; since July 2022, I have been an independent director of Nantong Taihe Chemical Co., Ltd.; and since October 2023, I have been an independent director of Zhejiang Longyuan Equipment Technology Co., Ltd. During my tenure as an independent director, I have not held any position other than that of independent director in the Company, nor have I held any position in the Company's major shareholders, and there are no relationships that could hinder my independent and objective judgment. I meet the qualifications and independence requirements for independent directors as stipulated in the Management Measures for Independent Directors of Listed Companies, the Self-Regulatory Guidelines No. 2 for Listed Companies on the Shenzhen Stock Exchange, and the Company's Articles of Association.
II. Annual Performance Overview
(A) Attendance at Board and Shareholder Meetings
- In 2025, the Company held a total of 14 board meetings, all of which I attended diligently and voted in favor of all resolutions without objection.
- In 2025, the Company held 4 shareholder meetings, and I attended 2 of them.
I believe that the board and shareholder meetings convened in 2025 complied with legal procedures, and all significant operational decisions and other major matters followed relevant procedures, thus being legal and effective. Therefore, I expressed my support for all board proposals and other matters without raising objections, dissent, or abstentions.